Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study
Research article
Published on
Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 진단,
Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 진단,
[키워드] admitted to ICU
Affect
affecting
Analysis
Antwerp
Aspergillus
autophagy
Belgium
Bronchoalveolar lavage fluid
bronchoalveolar lavage sample
bronchoalveolar lavage samples
calculate
Cell
chemokines
collected
Concentration
conidia
COVID-19
Critically ill patient
Cytokines
development
diagnose
differentially expressed
disrupting
downregulated
downregulation
elevated
Eligible patients
encoding protein
enrichment analysis
epithelial
European
expression
expression data
finding
foundation
fraction
France
function
funding
Gene expression analysis
growth factor
Horizon
hospital
hyphae
ICU
IFNγ
IL-1β
Immunity
in vivo
increased mortality
Influenza
Influenza virus
Innate immunity
intensive care
invasive
invasive ventilation
investigated
kill
killing
lung epithelial
Max Planck Society
network
neutrophil
Neutrophils
Non-invasive
pathophysiology
pathway
Pathway analysis
Pathways
Patient
patients
patients with COVID-19
patients with influenza
performed
phagocytosis
Protein
recruited
Regional
retrieved
SARS-COV-2 infection
SARS-CoV-2 RNA
several gene
significantly
significantly lower
spores
TNF-α
tracheobronchial
transcriptomics
Treatment
Type I IFN
type II IFN
university
University Hospitals Leuven
were used
[DOI] 10.1016/S2213-2600(22)00259-4 [Article Type] Research article
[DOI] 10.1016/S2213-2600(22)00259-4 [Article Type] Research article